Published on May 23, 2026

Eczema and Retinal Detachment: New Research Reveals Higher Eye Surgery Risks

Atopic dermatitis, commonly known as eczema, is widely recognized as a chronic skin condition that causes itching, redness, and inflammation. However, new medical research suggests that its impact may extend far beyond the skin. A recent large-scale study found that people with atopic dermatitis may face a significantly higher risk of retinal detachment and complications after retinal surgery.

The findings are drawing attention among dermatologists, ophthalmologists, and patients alike because retinal detachment is considered a serious eye emergency that can potentially lead to permanent vision loss if not treated quickly.

Understanding Atopic Dermatitis and Eye Health

Atopic Dermatitis is a long-term inflammatory disease that affects millions of adults and children worldwide. The condition is associated with immune system dysregulation, chronic inflammation, and several systemic health complications.

Researchers have increasingly explored how eczema may influence eye health. Previous studies have linked atopic dermatitis with cataracts, keratoconus, and chronic eye irritation. This latest research expands that understanding by examining its relationship with retinal detachment and postoperative complications.

What Is Retinal Detachment?

Retinal Detachment occurs when the retina separates from the back of the eye. The retina is responsible for converting light into signals that the brain interprets as vision.

Symptoms may include:

  • Sudden flashes of light
  • Floaters in vision
  • A shadow or curtain effect across the visual field
  • Sudden blurred vision

Without urgent treatment, retinal detachment can result in severe or permanent vision loss.

Overview of the Study

The study titled Association of Atopic Dermatitis with Retinal Detachment and Postoperative Proliferative Vitreoretinopathy Risk analyzed electronic health record data from more than 127 million patients across 72 healthcare organizations in the United States.

Researchers conducted a retrospective population-based cohort study involving adults aged 18 years and older between March 2006 and March 2026.

The study compared patients diagnosed with atopic dermatitis against matched individuals without the condition. Researchers used propensity score matching to balance demographic factors, smoking history, corticosteroid exposure, and ocular comorbidities.

Key Findings From the Research

The researchers identified more than 285,000 individuals with atopic dermatitis and over 2.8 million without the condition. After matching participants for fair comparison, each cohort included 274,547 patients.

The results showed a substantial increase in retinal risks among eczema patients.

Increased Risk of Retinal Detachment

Within five years, patients with atopic dermatitis had:

  • A 0.7% rate of retinal detachment diagnosis compared with 0.2% in controls
  • A hazard ratio of 2.74 for retinal detachment diagnosis
  • A significantly higher likelihood of requiring retinal detachment repair surgery

The study also found:

  • Retinal detachment repair occurred in 0.2% of eczema patients compared with 0.04% of controls
  • The hazard ratio for retinal detachment surgery was 4.56

These findings indicate that eczema patients may be more than four times as likely to undergo retinal detachment repair.

Higher Risk of Postoperative Complications

The study further evaluated patients who underwent retinal detachment surgery. Researchers specifically examined the risk of postoperative proliferative vitreoretinopathy.

Proliferative Vitreoretinopathy, commonly abbreviated as PVR, is one of the most serious complications after retinal detachment repair. It occurs when scar tissue develops on the retina, causing traction and potentially leading to recurrent detachment.

Among patients who had retinal surgery:

  • 5.9% of eczema patients developed PVR compared with 4.0% of controls
  • Patients with atopic dermatitis had a 45% increased risk of PVR
  • Complex retinal detachment repair procedures were also more common

Complex retinal repair occurred in:

  • 8.9% of eczema patients
  • 6.6% of non-eczema patients

These results suggest that inflammation associated with eczema may contribute to poorer surgical outcomes.

Why Might Eczema Affect the Retina?

Although the study did not establish direct causation, researchers proposed several possible explanations.

Chronic Inflammation

Atopic dermatitis is associated with systemic inflammation and immune activation. Persistent inflammatory processes may affect delicate retinal tissues and healing mechanisms after surgery.

Eye Rubbing Behavior

Many eczema patients experience chronic itching around the eyes and may rub them frequently. Long-term eye rubbing has previously been associated with structural eye damage and retinal complications.

Corticosteroid Exposure

Systemic corticosteroids are commonly used in severe eczema management. Prolonged steroid use may contribute to ocular complications in some patients, although the researchers attempted to account for this factor during analysis.

Clinical Implications for Patients and Doctors

The findings suggest that patients with eczema may benefit from increased awareness regarding retinal symptoms.

Doctors may consider:

  • Educating eczema patients about warning signs of retinal detachment
  • Recommending prompt ophthalmologic evaluation for new visual symptoms
  • Monitoring postoperative retinal surgery patients more closely if they have a history of eczema

Early diagnosis remains critical because retinal detachment outcomes are strongly influenced by treatment timing.

Important Limitations of the Study

While the research provides important insights, several limitations should be considered.

The study relied on electronic health records and diagnostic coding, which may contain inaccuracies or incomplete data. Researchers also noted that they could not confirm whether postoperative PVR occurred specifically in the operated eye.

Additionally, retrospective studies can identify associations but cannot definitively prove causation.

Future prospective clinical studies will be needed to better understand the biological relationship between eczema and retinal disease.

What This Means for People With Eczema

Most individuals with eczema will never experience retinal detachment. However, the study highlights the importance of paying attention to sudden visual symptoms and maintaining regular eye examinations, particularly for patients with severe or long-standing disease.

Anyone experiencing sudden flashes, floaters, peripheral shadows, or rapid vision changes should seek urgent medical care.

As researchers continue to explore the systemic effects of atopic dermatitis, this study reinforces the growing understanding that eczema is more than just a skin condition.

Conclusion

This nationwide study found that people with atopic dermatitis may face a significantly higher risk of retinal detachment, retinal surgery, postoperative proliferative vitreoretinopathy, and complex retinal repair procedures.

The research underscores the importance of interdisciplinary care between dermatologists and ophthalmologists, especially for patients with chronic inflammatory disease.

Further studies are needed to determine whether earlier screening, preventive strategies, or modified surgical monitoring could improve outcomes for patients with eczema-related retinal risks.

Source

Primary manuscript: Association of Atopic Dermatitis with Retinal Detachment and Postoperative Proliferative Vitreoretinopathy Risk by Alexander T. Hong, Forest Lin, Ehsan Rahimy, and Pradeep S. Prasad.

Disclaimer

This article is intended for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Readers should consult a qualified healthcare professional regarding any medical concerns or symptoms. Research findings discussed in this article describe statistical associations and do not prove direct causation.

Share this post

Explore Related Articles for Deeper Insights

Lilly’s VERVE-102 Gene Editing Therapy Shows Promising LDL Cholesterol Reduction in Early Trial
Cardiovascular disease remains one of the leading causes of death worldwide, and high levels of low-...
View
FDA Clears Differin Epiduo Acne Gel for Over the Counter Sale in the US
Acne treatment options in the United States are expanding after the U.S. Food and Drug Administratio...
View
Digital Handwriting Analysis May Help Detect Cognitive Decline in Older Adults
As the global population ages, healthcare professionals are searching for affordable and non-invasiv...
View

To get more personalized answers,
download now

rejoy-heath-logo